Advertisement PBR Staff Writer, Author at Pharmaceutical Business review - Page 1830 of 4440
Pharmaceutical Business review is using cookies

ContinueLearn More
Close
 

All articles by  

Cepheid Receives FDA Clearance For Xpert vanA

The company said that VanA is the antimicrobial resistance gene associated with vancomycin-resistant enterococci (VRE), a major healthcare-associated infection. The US Centers for Disease Control and Prevention reports

GenVault Introduces GenTegra RNA

GenVault has launched GenTegra RNA. GenTegraRNA is an inert chemical matrix that inactivates trace RNase in the liquid phase, providing an added level of RNA stability during sample

AAP Enters Into Agreement With Cardinal Health

American Associated Pharmacies (AAP) has selected Cardinal Health to be the exclusive pharmaceutical distributor for its nearly 2,000 independent pharmacy members, nationwide. The new, multi-year agreement, effective Jan

Cargill Enters Into Agreement With Westfeeds

Cargill has reached a manufacturing agreement with Westfeeds to buy billings feed mill and property. Officials from both companies anticipate that the sale will close by mid-February 2010.

Lanxess Takes Over PTAP Product Line From Clariant

Lanxess has acquired the Nipacide PTAP product line from Clariant effective January 1, 2010. The active ingredient, p-tert-amylphenol (PTAP) complements the phenolic active ingredients portfolio of Lanxess’ Material

Pfizer Gets EC Approval For Revatio

The European Commission (EC) has approved Pfizer’s Revatio (sildenafil) solution for injection in patients who are currently prescribed oral Revatio and who are temporarily unable to take oral

Alcon Responds To Novartis

The Alcon’s Independent Director Committee, in response to comments made by Novartis, stated its belief that Alcon has established certain important protections for the benefit of its minority